Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Repletion in Ovarian Cancer
NCT03028519Phase 1Completed
- Sponsor
- University of Oklahoma
- Start
- Jan 2017
- Primary completion
- Dec 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of vitamin d in Vitamin D deficiency (VDD), sponsored by University of Oklahoma. Primary endpoint: Treatment Related Morbidity at 1 year. Started Jan 2017; status: completed.
02
Drugs
vitamin d
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT03028519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03028519.